Overall Technical outlook

Price Summary

On 2025-10-16, Alembic Pharmaceuticals Limited's stock opened at 916.0, reached 940.0, hit a low of 913.35, and rose 1.9% to close at 933.4, with 66916 shares traded.
Over the past 52 weeks, the stock reached a maximum price of 1160.2 and a minimum price of 743.65.
The price outlook for APLLTD is between 900.0 and 1275.0, with an average expectation of 1056.3636, as estimated by 11 analysts.

Technicals

Support and Resistance: At 933.4, the price is held up by support at 879.6 and faces resistance at 934.7 for APLLTD. This suggests a trading range where 879.6 provides a base and 934.7 limits upward movement.
APLLTD supportResistance 9e6811
Support/Resistance for APLLTD


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
APLLTD aroon 9e6811
Aroon chart for Alembic Pharmaceuticals Limited


Bol. Bands: The current state of the BOLL BANDS is neutral for APLLTD, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
APLLTD bbands 9e6811
Bolinger Bands chart for Alembic Pharmaceuticals Limited


Parabolic SAR: The PSAR for APLLTD continues to signal a bullish outlook, establishing a crucial support level that may help sustain the current upward momentum. This level of support suggests that the market is likely to continue trending higher, providing a foundation for ongoing bullish movement.
APLLTD psar 9e6811
Parabolic Stop and Reverse chart for Alembic Pharmaceuticals Limited


Stochastic: The current reading of the STOCHASTIC is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
APLLTD stoch 9e6811
Stochastic chart for Alembic Pharmaceuticals Limited


Tripple Moving Agerage: The moving averages for the 20-50-100 periods are aligned for a bullish trend, but the slopes of the faster averages indicate that this strength may be short-lived. The weakening momentum in the shorter-term averages suggests that a reversal could be approaching, signaling a potential shift in the trend.
APLLTD trippleSMA 9e6811
Tripple SMA chart for Alembic Pharmaceuticals Limited


To accurately interpret a company's technical data, it is important to first examine its fundamentals. These include financial performance, management quality, and growth prospects. In addition, understanding the dynamics of the industry in which the company operates—such as competition, market trends, and regulatory factors—provides further insights. This combined analysis helps create a fuller picture, allowing for more precise conclusions to be drawn from the company's technical performance and stock behavior.